Greenway Announces First Quarter Financial Statements

KINGSVILLE, Ontario – August 29, 2023 – Greenway Greenhouse Cannabis Corporation (CSE:GWAY, OTCQB:GWAYF) (“Greenway” or the “Company”), a cultivator of high-quality greenhouse cannabis for the Canadian market, today reported its interim financial statements for the quarter ended June 30, 2023.

The Company is pleased to report the following results for the quarter ended June 30, 2023:


  • Over the quarter, Greenway reported a Positive Adjusted EBITDA of $16,408 on $1,174,189 of revenue
  • This is Greenways fifth consecutive quarter with Positive Adjusted EBITDA
  • Cost of sales comprised of $747,170 of cash expenses and $214,361 of amortization expense resulting in a total gross margin before inventory impairment and fair value adjustments of 18%
  • An average cash cost per gram expensed for the quarter of $0.67, comprised of all crop inputs and wages, bulk packaging, shipping and facility repairs and maintenance
  • A weighted average cash cost per gram of $0.66 of finished goods inventory on hand as at June 30, 2023


“We continue to deliver on what we believe separates us from our competitors, and that is our low cost and high quality production”, said Carl Mastronardi, President of Greenway. “We will continue to find ways to innovate and improve our growing techniques as we believe we can maintain our current costs while increasing our already high quality.”

“As we prepare to move into the consumer market, Greenway has been able to maintain our low overheads and cost of sales”, said Jamie D’Alimonte, CEO of Greenway. “I am proud that we have been able to deliver another Positive Adjusted EBITDA quarter, marking our fifth in a row. We will continue to see Greenway deliver on its progress down the pathway to profitability.”

A copy of the interim financial statements for the quarter ended June 30, 2023 2023 are prepared in accordance with International Financial Reporting Standards (IFRS) and the related Management’s Discussion and Analysis are available under the Company’s profile on All amounts expressed in this press release refer to Canadian dollars.

Non-IFRS Measures

Management uses a non-IFRS measure to assess the Company’s performance. Non-IFRS measures do not have any standardized meaning under IFRS and are not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies. Please refer to page

1 of the Company’s Management’s Discussion and Analysis for an explanation of the composition of Adjusted EBITDA, an explanation of how it provides useful information to an investor and a quantitative reconciliation to the most directly comparable financial measure under IFRS, all of which is hereby incorporated by reference in this press release.


Reconciliations of Non-IFRS Measures

The following table reconciles the non-IFRS measure to the most comparable IFRS measure for the three months ended June 30, 2023. This measure does not have any standardized meaning under IFRS and is not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies.

For the three months ended June 30, 2023
Net Income (Loss) (1,109,781)

Amortization – cost of sales



Fair value adjustment on sale of inventory
Fair value adjustment on growth of biological assets (48,226)
Amortization – operating 75,482
Share-based compensation

Investor relation services payable by common shares



Bad debt 268,237
Interest expense

Rental income




Adjusted EBITDA 16,408


This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws and may not be offered or sold in the United States unless registered under the 1933 Act and any applicable securities laws of any state of the United States or an applicable exemption from the registration requirements is available.


About Greenway

Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ontario, and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. More information can be found on and updates can be followed on Instagram, Twitter, Facebook, and LinkedIn.


The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.


Contact Information

Company Contact

Darren Peddle, Director and CFO

Greenway Greenhouse Cannabis Corporation



Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements that constitute forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding the Offering and the intended use of proceeds thereof, and the Company’s beliefs, plans, expectations, future, strategy, objectives, goals and targets, the development of future operations, and orientations regarding the future as of the date of this news release. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward- looking statements are typically identified by words such as: “believes”, “expects”, “aim”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “would”, “will”, “potential”, “scheduled” or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.

Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements, and includes those risks described in the Company’s final prospectus dated September 3, 2021, a copy of which is available under the Company’s profile at Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.